Enact Holdings, Inc. Stock Price, News & Analysis

Genworth Financial (NYSE: GNW) has received a credit rating upgrade from Moody's, with its backed senior unsecured debt rating improving to Baa3 from Ba1, representing a one-notch upgrade with a stable outlook.

The upgrade reflects Genworth's strengthened financial position and strategic execution, particularly highlighting the company's valuable 81% ownership stake in Enact. The Insurer Financial Strength ratings of Genworth's life insurance subsidiaries remain unchanged by this action.

Enact Holdings (Nasdaq: ACT) reported strong Q2 2025 financial results with GAAP net income of $168 million ($1.11 per diluted share) and adjusted operating income of $174 million ($1.15 per diluted share). The company achieved a 13.0% return on equity and grew its primary insurance in-force to $270 billion.

Key highlights include a PMIERs sufficiency of 165% ($2.0 billion above requirements), new insurance written of $13 billion (up 35% from Q1), and net premiums earned of $245 million. The company announced a $0.21 quarterly dividend and increased its full-year capital return guidance to approximately $400 million.

During Q2, Enact repurchased 2.4 million shares for $85 million and maintained strong persistency at 82%. The company's loss ratio improved to 10% from 12% in Q1 2025, while net investment income increased to $66 million.

Genworth Financial (NYSE:GNW) reported Q2 2025 results with net income of $51M ($0.12 per diluted share) and adjusted operating income of $68M ($0.16 per diluted share). The company's mortgage insurance subsidiary, Enact, delivered strong performance with $141M in adjusted operating income and distributed $94M in capital returns to Genworth.

Key highlights include $30M in share repurchases during the quarter at an average price of $7.01, bringing total repurchases to $620M since program inception. The Long-Term Care segment achieved $41M in gross incremental premium approvals. The company maintained a strong financial position with holding company cash and liquid assets of $248M and U.S. life insurance companies' RBC ratio of 304%.

Genworth Financial (NYSE: GNW) announced a favorable UK High Court ruling in a Payment Protection Insurance (PPI) case involving AXA and Santander. The court found Santander liable for PPI mis-selling losses and awarded AXA approximately £680 million ($911 million) in damages, interest, and costs.

Due to prior agreements with AXA, Genworth expects to recover approximately $750 million once the judgment is paid and any appeals are resolved. The company plans to use these funds for three main purposes: investing in CareScout growth, returning cash to shareholders through buybacks, and opportunistically reducing debt.

Enact Holdings (Nasdaq: ACT) has scheduled its second quarter 2025 earnings conference call for July 31, 2025, at 8:00 a.m. ET. The company will release its earnings report after market close on July 30, 2025.

The earnings release, summary presentation, and financial supplement will be accessible through Enact's investor relations website. Investors can participate in the Q&A session by pre-registering to obtain dial-in information, while those who wish to listen only can access the live webcast through the company's website. The webcast recording will remain available for one year.

Genworth Financial (NYSE: GNW) has scheduled its second quarter 2025 earnings conference call for July 31, 2025, at 9:00 a.m. ET. The company will release its earnings report after market close on July 30, 2025.

The conference call will be accessible via telephone (888-208-1820 or 323-794-2110) with conference ID #8808137, and through webcast registration at the investor relations website. Additionally, Genworth's subsidiary Enact Holdings (Nasdaq: ACT) will hold its Q2 earnings call on the same day at 8:00 a.m. ET.

Genworth Financial (NYSE: GNW) held its 2025 annual meeting of stockholders, where all ten director nominees were successfully re-elected to the board. Stockholders approved several key measures including: the advisory vote on named executive officer compensation, the 2025 Omnibus Incentive Plan, and ratified KPMG LLP as the company's independent registered public accounting firm for 2025. Additionally, stockholders approved an amendment to remove the "Pass-Through Voting" provision from the Amended and Restated Certificate of Incorporation of Genworth Holdings, Inc.

Enact reported strong Q1 2025 financial results with GAAP Net Income of $166 million ($1.08 per diluted share) and Adjusted Operating Income of $169 million ($1.10 per diluted share). The company achieved a Return on Equity of 13.1% and maintained a robust PMIERs Sufficiency of 165%.

Key highlights include Primary Insurance in-force of $268 billion, representing a 2% increase from Q1 2024. The company's persistency rate remained high at 84%, while new insurance written was $10 billion, with 94% monthly premium policies and 93% purchase originations.

Notable developments include Fitch Ratings upgrading EMICO's Financial Strength rating to 'A' and a 14% increase in quarterly dividend to $0.21 per share. The Board approved a new $350 million share repurchase program, demonstrating confidence in the company's financial strength and commitment to shareholder returns.

Genworth Financial reported Q1 2025 financial results with a net income of $54 million ($0.13 per diluted share) and adjusted operating income of $51 million ($0.12 per diluted share). The company executed $45M in share repurchases at an average price of $6.91 per share.

Key highlights include:

• Enact segment delivered $137M in adjusted operating income and distributed $76M to Genworth
• Long-term care insurance achieved $24M in gross incremental premium approvals
• CareScout Quality Network expanded to cover 90% of the U.S. aged 65-plus population
• U.S. life insurance companies maintained an RBC ratio of 304%
• Holding company ended with $211M in cash and liquid assets

The company continues to focus on delivering value through Enact, ensuring self-sustainability of legacy insurance operations, and scaling CareScout as a growth engine. Notable achievements include $590M in total share repurchases to date at an average price of $5.73 per share.